English
|
中文
Home
About Anbio
Return
Company Introduction
Company Qualification
Technical Cooperation
Products
Return
COVID-19
Return
Neutralizing Antibody
Antigen Test
Real-Time PCR
IgM/IgG Antibody
Immunofluorescence
Return
Cardiovascular
Inflammation
Apoplexy
Diabetes
Renal Function
Bone Calcium
Gastric Function
Thyroid Function
Sex Hormone
Tumor Markers
Allergy
Hair Trace Drugs
Colloidal Gold
Nucleic Aicd Assay
Detecting Instrument
Solutions
Return
COVID-19
Hair Drug Detection
Chest Pain Center
Stroke Center
Endocrine Clinic
Company News
Return
Company news
Industry trends
Recruitment
Contact Us
Home
About Anbio
Return
Company Introduction
Company Qualification
Technical Cooperation
Products
Return
COVID-19
Return
Neutralizing Antibody
Antigen Test
Real-Time PCR
IgM/IgG Antibody
Immunofluorescence
Return
Cardiovascular
Inflammation
Apoplexy
Diabetes
Renal Function
Bone Calcium
Gastric Function
Thyroid Function
Sex Hormone
Tumor Markers
Allergy
Hair Trace Drugs
Colloidal Gold
Nucleic Aicd Assay
Detecting Instrument
Solutions
Return
COVID-19
Hair Drug Detection
Chest Pain Center
Stroke Center
Endocrine Clinic
Company News
Return
Company news
Industry trends
Recruitment
Contact Us
English
|
中文
none
Company News
Company news
Industry trends
Your Current Position:
Company News
【Company news】
Anbio's Rapid COVID-19 Antigen Test (Colloidal Gold) has passed the Verification of the “National Institutes for Food and Drug Control”
2021-01-12
【Company news】
Good News:The latest 6 products have obtained CE EU market access qualification
2020-12-24
【Company news】
COVID-19 nucleic acid detection reagent obtains medical device registration certificate
2020-06-10
【Company news】
Anbio COVID-19 test kits enter the "white list" of the China Ministry of Commerce
2020-05-18